273 related articles for article (PubMed ID: 29066510)
21. HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity.
Aoki Y; Tosato G
Blood; 2004 Aug; 104(3):810-4. PubMed ID: 15073028
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS.
Chang Y; Moore PS
Infect Agents Dis; 1996 Oct; 5(4):215-22. PubMed ID: 8884366
[TBL] [Abstract][Full Text] [Related]
23. Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.
Dai L; Chen Y; Bonstaff K; Doyle L; Toole B; Parsons C; Qin Z
Cancer Lett; 2015 Jul; 362(2):158-66. PubMed ID: 25837851
[TBL] [Abstract][Full Text] [Related]
24. TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway.
Gruffaz M; Vasan K; Tan B; Ramos da Silva S; Gao SJ
Cancer Res; 2017 Dec; 77(24):7094-7108. PubMed ID: 29051178
[TBL] [Abstract][Full Text] [Related]
25. Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma.
Santiago JC; Goldman JD; Zhao H; Pankow AP; Okuku F; Schmitt MW; Chen LH; Hill CA; Casper C; Phipps WT; Mullins JI
PLoS Pathog; 2021 Jan; 17(1):e1008594. PubMed ID: 33465147
[TBL] [Abstract][Full Text] [Related]
26. Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected cells in KSHV/HIV-1-coinfected subjects without KSHV-associated diseases.
Campbell TB; Staskus KA; Folkvord J; White IE; Neid J; Zhang XQ; Connick E
J Infect Dis; 2005 Feb; 191(3):367-71. PubMed ID: 15633095
[TBL] [Abstract][Full Text] [Related]
27. New drug targets in Kaposi sarcoma.
Sullivan RJ; Pantanowitz L
Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
[TBL] [Abstract][Full Text] [Related]
28. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
29. Oral EBV and KSHV infection in HIV.
Webster-Cyriaque J; Duus K; Cooper C; Duncan M
Adv Dent Res; 2006 Apr; 19(1):91-5. PubMed ID: 16672557
[TBL] [Abstract][Full Text] [Related]
30. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
Brown EE; Fallin MD; Goedert JJ; Chen R; Whitby D; Foster CB; Lauria C; Alberg AJ; Messina A; Montella M; Rezza G; Vitale F; Chanock SJ;
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):633-7. PubMed ID: 15767342
[TBL] [Abstract][Full Text] [Related]
31. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
Kalt I; Masa SR; Sarid R
Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
[TBL] [Abstract][Full Text] [Related]
32. Infection of KSHV and Interaction with HIV: The Bad Romance.
Qin J; Lu C
Adv Exp Med Biol; 2017; 1018():237-251. PubMed ID: 29052142
[TBL] [Abstract][Full Text] [Related]
33. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and Kaposi sarcoma.
Martin JN
Adv Dent Res; 2011 Apr; 23(1):76-8. PubMed ID: 21441485
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
Gramolelli S; Ojala PM
Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
[TBL] [Abstract][Full Text] [Related]
35. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases.
Knowles DM; Cesarman E
Ann Oncol; 1997; 8 Suppl 2():123-9. PubMed ID: 9209655
[TBL] [Abstract][Full Text] [Related]
36. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
Schulz TF; Cesarman E
Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
[TBL] [Abstract][Full Text] [Related]
37. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance.
Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H
PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870
[TBL] [Abstract][Full Text] [Related]
38. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.
Mutlu AD; Cavallin LE; Vincent L; Chiozzini C; Eroles P; Duran EM; Asgari Z; Hooper AT; La Perle KM; Hilsher C; Gao SJ; Dittmer DP; Rafii S; Mesri EA
Cancer Cell; 2007 Mar; 11(3):245-58. PubMed ID: 17349582
[TBL] [Abstract][Full Text] [Related]
39. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Cesarman E; Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
